|
市場調査レポート
商品コード
1375193
欧州の医療用マリファナ市場の2028年予測-地域別分析-製品タイプ、用途、流通チャネル別Europe Medical Marijuana Market Forecast to 2028 - Regional Analysis - by Product Type, Application, and Distribution Channel |
||||||
|
|
|||||||
| 欧州の医療用マリファナ市場の2028年予測-地域別分析-製品タイプ、用途、流通チャネル別 |
|
出版日: 2023年08月22日
発行: The Insight Partners
ページ情報: 英文 118 Pages
納期: 即納可能
 |
- 全表示
- 概要
- 図表
- 目次
欧州の医療用マリファナ市場は、2022年の34億1,426万米ドルから2028年には97億338万米ドルに成長すると予測されています。2022年から2028年までのCAGRは19.0%と推定されます。
医療用マリファナ認可の増加が欧州医療用マリファナ市場の成長を後押し
欧州における医療用大麻の合法性に関する最近のイニシアチブは、大麻の治療可能性を受け入れ、認めようとする広範な動向を示しています。例えばドイツは、2017年に医療用大麻を合法化し、その強固な医療用大麻市場をリードする国の一つとなっています。同国は大麻治療の対象となる病状を拡大し、患者登録と医療用大麻の輸入が急増しました。フランスは2021年から2年間、特定の疾患に対する医療用大麻の実現可能性と有効性を評価する試験的プログラムに着手し、注目すべき一歩を踏み出しました。英国は2018年に医療用大麻を合法化し、専門医が特定の病状に対して大麻ベースの製品を処方することを許可しました。しかし、アクセス上の問題から、患者の利用しやすさを改善するための政府の見直しが求められています。
さらにイタリアは、さまざまな症状の患者に対応する確立された医療用大麻プログラムを誇っており、規制の合理化とアクセスの拡大に向けた努力が続けられています。先進的な薬物政策で有名なオランダでは、薬局を通じて医療用大麻を入手することができます。また、ルクセンブルクは欧州で初めて娯楽用大麻の使用を完全に合法化する計画を発表し、大麻に対する考え方が進化していることを示しています。一方、ギリシャは2017年に医療用大麻を合法化し、栽培、加工、流通への投資を促しています。これらの動きは、欧州における医療用大麻の状況の変化を反映しており、特定の医療ニーズを持つ患者に対する治療的価値を認める国が増加しています。
欧州の医療用マリファナ市場概要
欧州の医療用大麻市場は、ドイツ、英国、フランス、イタリア、スペイン、その他の欧州に分けられます。欧州地域は医療用マリファナ市場で大きなシェアを占めています。欧州は欧州医療用マリファナ市場で重要な位置を占めており、予測期間中に堅調な成長率を記録すると予測されています。同地域の市場成長の背景には、ライフサイエンス研究の活発化と研究開発への投資の増加があります。
欧州の医療用マリファナ市場の収益と2028年までの予測（金額）
欧州の医療用マリファナ市場のセグメンテーション
欧州の医療用マリファナ市場は、製品タイプ、用途、流通チャネル、国に区分されます。
製品別に基づき、欧州医療用マリファナ市場は乾燥形態とエキス形態に区分されます。2022年の欧州医療用マリファナ市場では、エキス剤が大きなシェアを占めています。
用途別では、欧州の医療用マリファナ市場は疼痛管理、トゥレット病、アルツハイマー病、片頭痛、うつ病と不安、多発性硬化症、がん、その他に区分されます。2022年の欧州医療用マリファナ市場では、疼痛管理分野が最大のシェアを占めています。
流通チャネルに基づき、欧州の医療用マリファナ市場は小売薬局、eコマース、その他に区分されます。小売薬局セグメントが2022年の欧州医療用マリファナ市場で最大のシェアを占めました。
国別では、欧州の医療用マリファナ市場はドイツ、英国、フランス、イタリア、スペイン、その他の欧州に区分されます。2022年の欧州医療用マリファナ市場はドイツが独占。
Aphria, Inc.、Canopy Growth Corporation、GW Pharmaceuticals、Panaxia Pharmaceutical Industries Ltd.、VIVO Cannabis Inc.などは、欧州医療用マリファナ市場で事業を展開する大手企業です。
目次
第1章 イントロダクション
第2章 欧州の医療用マリファナ市場-重要なポイント
第3章 調査手法
- 調査範囲
- 2次調査
- 1次調査
第4章 欧州の医療用マリファナ市場- 市場情勢
- イントロダクション
- 欧州-PEST分析
- 専門家の見解
第5章 欧州の医療用マリファナ市場：主要市場力学
- 市場促進要因
- 医療用マリファナ認可の増加
- 市場抑制要因
- 文化的・社会的スティグマ
- 市場機会
- 医療用マリファナ市場における医薬品との統合
- 今後の動向
- 医療用マリファナ市場における地域貿易と連携
- 影響分析
第6章 医療用マリファナ市場-欧州分析
- 欧州の医療用マリファナ市場の収益と予測分析
第7章 欧州の医療用マリファナ市場分析：製品別
- イントロダクション
- 欧州の医療用マリファナ市場：製品別（2021年、2028年）
- 乾燥形態
- エキス形態
第8章 欧州の医療用マリファナ市場分析：用途別
- イントロダクション
- 欧州の医療用マリファナ市場：用途別（2021年、2028年）
- 疼痛管理
- トゥレット障害
- アルツハイマー病
- 偏頭痛
- うつ病と不安神経症
- 多発性硬化症
- がん
- その他
第9章 欧州の医療用マリファナ市場：流通チャネル別
- イントロダクション
- 欧州の医療用マリファナ市場：流通チャネル別（2021年、2028年）
- 小売薬局
- eコマース
- その他
第10章 欧州の医療用マリファナ市場の収益と2028年までの予測：国別分析
- ドイツ
- 英国
- フランス
- イタリア
- スペイン
- その他の欧州
第11章 欧州の医療用マリファナ市場-業界情勢
- イントロダクション
- 欧州の医療用マリファナ市場の成長戦略（%）
- オーガニック開発
- 概要
- 無機的展開
- 概要
第12章 企業プロファイル
- VIVO Cannabis Inc
- Panaxia Pharmaceutical Industries Ltd.
- Aphria, Inc.
- Canopy Growth Corporation
- GW Pharmaceuticals
第13章 付録
List Of Tables
- Table 1. Germany: Europe Medical Marijuana Market , by Product- Revenue and Forecast to 2028 (US$ Million)
- Table 2. Germany: Europe Medical Marijuana Market , by Application - Revenue and Forecast to 2028 (US$ Million)
- Table 3. Germany: Europe Medical Marijuana Market , by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
- Table 4. UK: Europe Medical Marijuana Market , by Product- Revenue and Forecast to 2028 (US$ Million)
- Table 5. UK: Europe Medical Marijuana Market , by Application - Revenue and Forecast to 2028 (US$ Million)
- Table 6. UK: Europe Medical Marijuana Market , by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
- Table 7. France: Europe Medical Marijuana Market , by Product- Revenue and Forecast to 2028 (US$ Million)
- Table 8. France: Europe Medical Marijuana Market , by Application - Revenue and Forecast to 2028 (US$ Million)
- Table 9. France: Europe Medical Marijuana Market , by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
- Table 10. Italy: Europe Medical Marijuana Market , by Product- Revenue and Forecast to 2028 (US$ Million)
- Table 11. Italy: Europe Medical Marijuana Market , by Application - Revenue and Forecast to 2028 (US$ Million)
- Table 12. Italy: Europe Medical Marijuana Market , by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
- Table 13. Spain: Europe Medical Marijuana Market , by Product- Revenue and Forecast to 2028 (US$ Million)
- Table 14. Spain: Europe Medical Marijuana Market , by Application - Revenue and Forecast to 2028 (US$ Million)
- Table 15. Spain: Europe Medical Marijuana Market , by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
- Table 16. Rest of Europe: Europe Medical Marijuana Market , by Product- Revenue and Forecast to 2028 (US$ Million)
- Table 17. Rest of Europe: Europe Medical Marijuana Market , by Application - Revenue and Forecast to 2028 (US$ Million)
- Table 18. Rest of Europe: Europe Medical Marijuana Market , by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
- Table 19. Organic Developments in the Europe Medical Marijuana Market
- Table 20. Inorganic Developments in the Europe Medical Marijuana Market
- Table 21. Glossary of Terms for Europe Medical Marijuana Market
List Of Figures
- Figure 1. Europe Medical Marijuana Market Segmentation
- Figure 2. Europe Medical Marijuana Market , By Country
- Figure 3. Europe Medical Marijuana Market Overview
- Figure 4. Extract Form Held Largest Share of Product Segment in Europe Medical Marijuana Market
- Figure 5. The UK to Show Remarkable Growth During Forecast Period
- Figure 6. Europe PEST Analysis
- Figure 7. Europe Medical Marijuana Market - Revenue Forecast and Analysis - 2020- 2028
- Figure 8. Europe Medical Marijuana Market Revenue Share, by Product (2021 and 2028)
- Figure 9. Dried Form: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 10. Extract Form: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 11. Europe Medical Marijuana Market Revenue Share, by Application (2021 and 2028)
- Figure 12. Pain Management: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 13. Tourette's: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 14. Alzheimer's Disease: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 15. Migraines: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 16. Depression and Anxiety: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 17. Multiple Sclerosis: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 18. Cancer: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 19. Others: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 20. Europe Medical Marijuana Market , by Distribution Channel (2021 and 2028)
- Figure 21. Retail Pharmacy: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 22. E-commerce: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 23. Others: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 24. Europe Medical Marijuana Market , by Key Country - Revenue (2021) (US$ Million)
- Figure 25. Europe Medical Marijuana Market , by Country, 2021 & 2028 (%)
- Figure 26. Germany: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 27. UK: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 28. France: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 29. Italy: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 30. Spain: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 31. Rest of Europe: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 32. Growth Strategies in the Europe Medical Marijuana Market (%)
The Europe medical marijuana market is expected to grow from US$ 3,414.26 million in 2022 to US$ 9,703.38 million by 2028. It is estimated to register a CAGR of 19.0% from 2022 to 2028.
Increasing Approvals of Medical Marijuana Fuels Europe Medical Marijuana Market Growth
Recent initiatives related to the legality of medical marijuana in Europe have been indicative of a broader trend toward acceptance and acknowledgment of the therapeutic potential of cannabis. Germany, for instance, stands as one of the leaders in its robust medical marijuana market, having legalized it in 2017. The country has expanded the list of eligible medical conditions for cannabis treatment, witnessing a surge in patient registrations and imports of medical marijuana. France embarked on a two-year pilot program in 2021 to assess the feasibility and efficacy of medical cannabis for specific ailments, marking a notable step forward. The UK legalized medical marijuana in 2018, permitting a specialist doctor to prescribe cannabis-based products for specific medical conditions. However, access issues have prompted a government review to improve patient accessibility.
Moreover, Italy boasts an established medical cannabis program that caters to patients with various conditions, with ongoing efforts to streamline regulations and broaden access. The Netherlands, renowned for its progressive drug policies, provides access to medical marijuana through pharmacies. Also, Luxembourg announced plans to become the first European nation to fully legalize recreational cannabis use, signaling evolving attitudes toward cannabis. Greece, on the other hand, legalized medical cannabis in 2017, encouraging investments in cultivation, processing, and distribution. These developments collectively reflect the shifting landscape of medical marijuana in Europe, with an increasing number of countries recognizing its therapeutic value for patients with specific medical needs.
Europe Medical Marijuana Market Overview
The Europe medical marijuana market is divided into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The Europe region holds a significant market share in the medical marijuana market. Europe occupies a significant position in the Europe medical marijuana market and is estimated to register a robust growth rate over the forecast period. The market growth in the region is attributed to the growing life science research and increasing investment in research and development.
Europe Medical Marijuana Market Revenue and Forecast to 2028 (US$ Million)
Europe Medical Marijuana Market Segmentation
The Europe medical marijuana market is segmented into product type, application, distribution channel, and country.
Based on product type, the Europe medical marijuana market is segmented into dried form and extract form. The extract form segment held a larger share of the Europe medical marijuana market in 2022.
Based on application, the Europe medical marijuana market is segmented into pain management, Tourette's, Alzheimer's disease, migraines, depression and anxiety, multiple sclerosis, cancer, and others. The pain management segment held the largest share of the Europe medical marijuana market in 2022.
Based on distribution channel, the Europe medical marijuana market is segmented into retail pharmacy, e-commerce, and others. The retail pharmacy segment held the largest share of the Europe medical marijuana market in 2022.
Based on country, the Europe medical marijuana market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe medical marijuana market in 2022.
Aphria, Inc.; Canopy Growth Corporation; GW Pharmaceuticals; Panaxia Pharmaceutical Industries Ltd.; and VIVO Cannabis Inc are some of the leading companies operating in the Europe medical marijuana market.
Reasons to Buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe medical marijuana market .
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in Europe medical marijuana market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table Of Contents
1. Introduction
- 1.1 Scope of the Study
- 1.2 The Insight Partners Research Report Guidance
- 1.3 Market Segmentation
- 1.3.1 Europe Medical Marijuana Market - by Product
- 1.3.2 Europe Medical Marijuana Market - by Application
- 1.3.3 Europe Medical Marijuana Market - by Distribution Channel
- 1.3.4 Europe Medical Marijuana Market - by Country
2. Europe Medical Marijuana Market - Key Takeaways
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. Europe Medical Marijuana Market - Market Landscape
- 4.1 Overview
- 4.2 Europe- PEST Analysis
- 4.3 Expert Opinion
5. Europe Medical Marijuana Market - Key Market Dynamics
- 5.1 Market Drivers
- 5.1.1 Increasing Approvals of Medical Marijuana
- 5.2 Market Restraints
- 5.2.1 Cultural and Social Stigma
- 5.3 Market Opportunities
- 5.3.1 Pharmaceutical Integration in the Medical Marijuana Market
- 5.4 Future Trends
- 5.4.1 Regional Trade and Collaboration in the Medical Marijuana Market
- 5.5 Impact Analysis
6. Medical Marijuana Market -Europe Analysis
- 6.1 Europe Medical Marijuana Market Revenue Forecast and Analysis
7. Europe Medical Marijuana Market Revenue and Forecast To 2028- by Product
- 7.1 Overview
- 7.2 Europe Medical Marijuana Market Revenue Share, by Product (2021 and 2028)
- 7.3 Dried Form
- 7.3.1 Overview
- 7.3.2 Dried Form: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- 7.4 Extract Form
- 7.4.1 Overview
- 7.4.2 Extract Form: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
8. Europe Medical Marijuana Market Analysis - by Application
- 8.1 Overview
- 8.2 Europe Medical Marijuana Market Revenue Share, by Application (2021 and 2028)
- 8.3 Pain Management
- 8.3.1 Overview
- 8.3.2 Pain Management: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- 8.4 Tourette's
- 8.4.1 Overview
- 8.4.2 Tourette's: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- 8.5 Alzheimer's Disease
- 8.5.1 Overview
- 8.5.2 Alzheimer's Disease: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- 8.6 Migraines
- 8.6.1 Overview
- 8.6.2 Migraines: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- 8.7 Depression and Anxiety
- 8.7.1 Overview
- 8.7.2 Depression and Anxiety: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- 8.8 Multiple Sclerosis
- 8.8.1 Overview
- 8.8.2 Multiple Sclerosis: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- 8.9 Cancer
- 8.9.1 Overview
- 8.9.2 Cancer: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- 8.10 Others
- 8.10.1 Overview
- 8.10.2 Others: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
9. Europe Medical Marijuana Market - by Distribution Channel
- 9.1 Overview
- 9.2 Europe Medical Marijuana Market , by Distribution Channel (2021 and 2028)
- 9.3 Retail Pharmacy
- 9.3.1 Overview
- 9.3.2 Retail Pharmacy: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- 9.4 E-Commerce
- 9.4.1 Overview
- 9.4.2 E-commerce: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- 9.5 Others
- 9.5.1 Overview
- 9.5.2 Others: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
10. Europe Medical Marijuana Market Revenue and Forecast to 2028 - Country Analysis
- 10.1 Overview
- 10.1.1 Europe Medical Marijuana Market , by Country, 2021 & 2028 (%)
- 10.1.1.1 Germany: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.1 Germany: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.2 Germany: Europe Medical Marijuana Market , by Product- Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.3 Germany: Europe Medical Marijuana Market , by Application - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.4 Germany: Europe Medical Marijuana Market , by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2 UK: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.1 UK: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.2 UK: Europe Medical Marijuana Market , by Product- Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.3 UK: Europe Medical Marijuana Market , by Application - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.4 UK: Europe Medical Marijuana Market , by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3 France: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.1 France: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.2 France: Europe Medical Marijuana Market , by Product- Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.3 France: Europe Medical Marijuana Market , by Application - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.4 France: Europe Medical Marijuana Market , by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.4 Italy: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.4.1 Italy: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.4.2 Italy: Europe Medical Marijuana Market , by Product- Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.4.3 Italy: Europe Medical Marijuana Market , by Application - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.4.4 Italy: Europe Medical Marijuana Market , by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.5 Spain: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.5.1 Spain: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.5.2 Spain: Europe Medical Marijuana Market , by Product- Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.5.3 Spain: Europe Medical Marijuana Market , by Application - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.5.4 Spain: Europe Medical Marijuana Market , by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.6 Rest of Europe: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.6.1 Rest of Europe: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.6.2 Rest of Europe: Europe Medical Marijuana Market , by Product- Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.6.3 Rest of Europe: Europe Medical Marijuana Market , by Application - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.6.4 Rest of Europe: Europe Medical Marijuana Market , by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1 Germany: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1 Europe Medical Marijuana Market , by Country, 2021 & 2028 (%)
11. Europe Medical Marijuana Market - Industry Landscape
- 11.1 Overview
- 11.2 Growth Strategies in the Europe Medical Marijuana Market (%)
- 11.3 Organic Developments
- 11.3.1 Overview
- 11.4 Inorganic Developments
- 11.4.1 Overview
12. Company Profiles
- 12.1 VIVO Cannabis Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
- 12.2 Panaxia Pharmaceutical Industries Ltd.
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
- 12.3 Aphria, Inc.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
- 12.4 Canopy Growth Corporation
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
- 12.5 GW Pharmaceuticals
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
13. Appendix
- 13.1 About The Insight Partners
- 13.2 Glossary of Terms for Europe Medical Marijuana Market
